Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma

Objectives. Scatter factor (hepatocyte growth factor) (SF/HGF) is a multifu nctional polypeptide growth factor that has been implicated in tumor prolif eration, angiogenesis, invasiveness, and metastasis. Little is known of the expression of SF/HGF in human prostatic carcinoma. The aims of this invest igation were to quantitate the level of SF/HGF expression in benign versus malignant human prostatic tissues and to assess regulation of SF/HCF expres sion by human prostatic stromal myofibroblasts. Methods. We determined the level of SF/HGF expression in 10 human prostatic tissue samples (5 benign, 5 carcinoma) by Western blot analysis. Five puri fied growth factors-basic fibroblast growth factor (bFGF), interleukin-1 be ta (IL-1 beta), platelet-derived growth factor (PDGF), Vascular endothelial growth factor (VEGF), and endothelial growth factor (EGF)-were tested for their capacity to induce SF/HGF expression by a human prostatic stromal myo fibroblastic cell line, as assessed by enzyme-linked immunosorbent assay. S upernatant from the normal PrEC prostatic epithelial cell fine and the DU 1 45 carcinoma cell line were assayed for SF/HGF-inducing activity. Results. SF/HGF exhibited a mean fourfold overexpression in carcinoma tissu es compared with benign prostatic tissue. Significant stimulation of SF/HGF expression by prostatic stromal myofibroblasts was detected for IL-1 beta (8.1-fold), PDGF (6.2-fold), bFGF (4.0-fold), VEGF (3.7-fold), and EGF (2.9 -fold). DU 145-conditioned media, but not the PrEC-conditioned media, conta ined SF/HGF-inducing activity, which was determined to include IL-1 beta, b FGF, and PDGF by antibody-blocking experiments. Conclusions. SF/HGF is overexpressed in human prostatic carcinoma tissues. Prostatic carcinoma cell stimulation of SF/HCF expression by adjacent benig n myofibroblastic cells as a type of epithelial-stromal paracrine interacti on could potentially influence prostatic carcinoma cell behaviors. UROLOGY 56: 1071-1074, 2000. (C) 2000, Elsevier Science Inc.